Serum homocysteine, vitamin B12, and folate, and the prevalence and incidence of posterior subcapsular cataract

• Published in: Investigative ophthalmology & visual science Vol. 56; no. 1; pp. 216 - 220
• Main Authors: Tan, Ava Grace, Mitchell, Paul, Rochtchina, Elena, Flood, Victoria M, Cumming, Robert G, Wang, Jie Jin
• Format: Journal Article
• Language: English
• Published: United States 18.11.2014
• Subjects: Aged; Biomarkers - blood; Cataract - blood; Cataract - epidemiology; Cross-Sectional Studies; Female; Folic Acid - blood; Follow-Up Studies; Homocysteine - blood; Humans; Incidence; Male; Middle Aged; New South Wales - epidemiology; Population Surveillance - methods; Prevalence; Retrospective Studies; Vitamin B 12 - blood; New South Wales; homocysteine; cataract; epidemiology
• ISSN: 0146-0404; 1552-5783
• DOI: 10.1167/iovs.14-15531

We assessed associations between serum levels of homocysteine, vitamin B12, and folate, and the prevalence and 5-year incidence of posterior subcapsular cataract (PSC) in Blue Mountains Eye Study participants. We examined 3508 participants aged 49+ years during 1997 to 2000, including 2334 (75.1% of survivors) original and 1174 (85.2% of those eligible) newly recruited subjects. Five years later (2002-2004), 1952 (76.6% of survivors) original participants were re-examined. Detailed examinations, including lens photographs and fasting blood tests, were conducted at both visits. Logistic regression models estimated odds ratios (OR) and 95% confidence intervals (CI) after multivariable adjustment. In this population, those with PSC were older, less likely to have higher education, and more likely to have diabetes and myopia. The PSC prevalence was 5.7% (150/2644). Higher levels of homocysteine (per SD; OR, 1.17; 95% CI, 1.00-1.37) and lower levels of folate (per SD; OR, 1.24; 95% CI, 0.99-1.56) were associated with prevalent PSC. There was significant interaction (P < 0.05) between vitamin B12 and homocysteine; for B12 ≥125 pmol/L, 28% higher PSC prevalence was associated with homocysteine (per SD; OR, 1.28; 95% CI, 1.09-1.52); however, for B12 <125 pmol/L, nonsignificant lower PSC prevalence was associated with homocysteine (per SD; OR, 0.16; 95% CI, 0.02-1.57). The 5-year PSC incidence was 5.7% (n = 59/1030) with no significant associations with homocysteine, B12, and folate. Higher serum homocysteine level was associated with PSC prevalence in this population. Vitamin B12 status seemed to modify this association. Lack of longitudinal association could have resulted from insufficient study power.